Submitted by Anonymous (not verified) on 3 August 2023 - 13:22
Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Diabetes Mellitus, Type 2, Date of authorisation: 15/11/2015, Revision: 20, Status: Authorised
Source: